Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Smartwatch Tracking of Walking and Daily Activity in Bone Cancer Patients

Tests a smartwatch to track walking and daily activity in adults with bone cancer.

Plain-language title generated from the registry record
Registry title: Musculoskeletal Cancers Remote Monitoring and Care

Key facts

Where
Cleveland, United StatesSee the site

Where in United States

  • Case Comprehensive Cancer Center, Cleveland Clinic FoundationCleveland, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Case Comprehensive Cancer Center
Trial code
NCT07129226
Record updated
6 August 2026
Original description
This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.Read full original descriptionShow less

Musculoskeletal Cancers Remote Monitoring and Care

This study aims to evaluate how walking stability and the ability to perform daily activities change during cancer treatment, and whether a smartwatch can detect these changes. The goal is to develop proactive, personalized tools that automatically monitor treatment response and predict potential complications. To support future implementation, the study will assess the feasibility of wearing a smartwatch for at least 12 hours per day, using a mobile application, and completing weekly questionnaires among patients with primary osteosarcoma or metastatic bone disease.

Inclusion: primary sarcoma or metastatic bone disease of the lower extremities or pelvis; undergoing evaluation for (or have recently undergone) non-surgical or surgical intervention; recent history of home ambulation.

Exclusion: tattoos located on the skin of the wrist or forearm where the watch will be placed or other skin conditions preventing adequate sensor function; amputation or other disease of the arm or skin that prevents wear of a smart-watch device; under 18 years of age at the time of study enrolment; inability to comprehend consent form and give informed consent; no access to a smartphone (iOS or Android) to interface with watch application; inability to tolerate watch for at least 12 hours per day on at least 80% of days in a four-week period.

ClinicalTrials.gov NCT07129226